Wednesday, August 15, 2007 by: Mike Adams
Researchers at Massachusetts General Hospital have reported that omega-3 fatty acid is highly effective in treating children with ADD, ADHD and bipolar disorder. The study was reported in the journal European Neuropsychopharmacology in February 2007.
"Results from this prospective, open study of monotherapy with omega-3 fatty acids in the over-the-counter product OmegaBrite suggest that manic symptoms can be rapidly reduced in youths with BPD with a safe and well-tolerated nutritional supplement," wrote lead researcher Dr. Janet Wozniak.
The high-EPA supplement of Omega-3 fatty acids, called OmegaBrite, was tested for effectiveness and safety on 20 boys and girls with bipolar disorder, ages 6 to 17 years old, over an eight-week period. Half of the participants experienced a rapid 30 percent reduction in symptoms with no side effects.
"What this study shows is that every child with ADD, bipolar or any other mood disorder should be on OmegaBrite," said Dr. John Ratey, author of the best-selling Driven to Distraction and a well-respected expert on ADD. "And the only side effect is a longer life."
"This is great news for parents," said Dr. Carol Locke, who served on the Harvard Medical School faculty for 14 years before creating OmegaBrite. "Parents are always struggling with how best to help their children. It is incredibly gratifying to develop a product that offers a safe mood stabilizer and natural anti-depressant."
The study demonstrated that supplements reduced the participating children's Young Mania Rating Scale scores (YMRS) -- the standard rating scale for children with bipolar disorder -- by 30 percent. The same research team conducted a similar study with risperidone or olanzapine, the two most commonly prescribed drugs for the disorder. The pharmaceuticals treated the children's disorders but led to side effects including diabetes.
Other commonly prescribed drugs such as lithium, divalproex and carbamazepine are only minimally effective or fraught with adverse effects, the researchers noted.
"EPA and DHA are essential fatty acids that the body cannot make so we must obtain them in our diet, which is very hard to do, or by supplements," said Locke. "An imbalance of omega-6 and omega-3 can result in an overall inflammatory response and related disorders such as depression, cardiac disease, cancer, dementia, asthma and rheumatoid arthritis."
Locke concluded, "Over the next five years, we will see Omega-3 fatty acids become a foundation of health."
ADHD is a fictitious disease invented by the pharmaceutical industry to sell amphetamine drugs to children. The conventional medical industry doesn't want to talk about nutritional cures for diseases or disorders because they know that if consumers were made aware of how simply and inexpensively these conditions could be resolved with nutrition, sales of pharmaceuticals would plummet. Symptoms of ADHD are easily eliminated in 80 percent of children within two weeks by merely supplementing with omega-3 oils and eliminating processed foods (especially refined sugars) from kids' diets.
The psychiatric industry does not promote nutrition as a method for preventing or treating depression, bipolar disorder, ADHD or other mental or behavioral conditions. Instead, it works to keep consumers ignorant of such solutions and pretends that these diseases are caused by "brain chemistry imbalances" that can only be corrected with synthetic patented chemicals (pharmaceuticals). Essentially, modern psychiatry believes that all such disorders are caused by a pharmaceutical deficiency. This belief conveniently serves the profit motives of the drug companies which now virtually run modern psychiatry.
Information about OmegaBrite can be found at http://www.omegabrite.com
NewsTarget has no financial relationship whatsoever with OmegaBrite (or any nutritional supplement company) and earns nothing from sales of this product.